Literature DB >> 6270944

Distribution of prostaglandin E2 and prostaglandin F2 alpha receptors in human myometrium.

T Bauknecht, B Krahe, U Rechenbach, H P Zahradnik, M Breckwoldt.   

Abstract

Human myometrium was studied for specific binding of PGE2 and PGF2 alpha. PGF2 alpha-binding was almost undetectable, but specific binding sites for PGE2 with high affinity (KD = 2.7 +/- 0.4 x 10(-9) M were demonstrated. The binding capacity for PGE2 exhibited a topically different distribution pattern with the highest values in the central parts and low to undetectable levels in the cervical region. Binding characteristics were analyzed by receptor kinetics, revealing a homogeneous receptor population. Binding capacity in uteri obtained from post-menopausal women was of the order of 900-940 fmol/mg protein. Oestrogen pre-treatment and pregnancy were associated with a 3-fold reduction of the PGE2-binding capacity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270944     DOI: 10.1530/acta.0.0980446

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  5 in total

1.  The effect of prostaglandins on experimental storage disease in rats.

Authors:  K Joh; U N Riede; H P Zahradnik
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

2.  The effect of prostaglandins on the lysosomal function in the cervix uteri.

Authors:  K Joh; U N Riede; H P Zahradnik
Journal:  Arch Gynecol       Date:  1983

3.  In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium.

Authors:  J Senior; R Sangha; G S Baxter; K Marshall; J K Clayton
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

4.  In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.

Authors:  J Senior; K Marshall; R Sangha; J K Clayton
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  Effects of a single administration of prostaglandin F2alpha, or a combination of prostaglandin F2alpha and prostaglandin E2, or placebo on fertility variables in dairy cows 3-5 weeks post partum, a randomized, double-blind clinical trial.

Authors:  Gaby Hirsbrunner; Heinz W Burkhardt; Adrian Steiner
Journal:  Reprod Biol Endocrinol       Date:  2006-12-21       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.